StockWatch
·

SANDU PHARMACEUTICALS LTD. Q4 FY26 Results

SANDUPHQQ4 FY26 Results
Filing
MetricValue (₹ Cr)Q3 FY26Q4 FY25
Revenue16.8510.2%19.8%
Total Income17.228.3%21.8%
Expenditure16.478.1%19.4%
PBT0.7512.6%118.2%
Net Profit0.0495.5%86.7%
OPM3.40%2.15pp0.22pp
NPM0.25%4.94pp2.06pp
EPS0.0496.0%88.2%
View full financials

Informational and educational content only. Not investment advice.